Jenoptik Ag · XETR:JEN
Jenoptik — Q4 2025 Earnings Presentation
19 slides from Jenoptik's earnings presentation, Mar 25, 2026
Slide 1: JENOPTIK AG – Financial Statements 2025
JENOPTIK AG – Financial Statements 2025 Dr. Prisca Havranek-Kosicek | March 25, 2026 © Copyright Jenoptik. All rights reserved.
Slide 2: Disclaimer
Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the
Slide 3: Fiscal year 2025
Fiscal year 2025
Slide 4: Profitable growth expected for 2026; difficult market environment influenced 2025
Profitable growth expected for 2026; difficult market environment influenced 2025 Good progress on strategic goals: − New organizational structure implemented – lean, accountable, transparent Semiconductor & − Opening of new micro-optics Fab in Dresden major milestone Advanced Manufacturing − Gained
Slide 5: Order intake below prior year, demand in semi equipment industry stabilized in H2
Order intake below prior year, demand in semi equipment industry stabilized in H2 Order intake in MEUR In million euros 2025 2024 Change in % 1200 −3.4% 1,027.7 Semiconductor & Advanced Manufacturing 404.0 453.6 −10.9 992.8 Biophotonics 250.2 209.6 19.3 245.8 215.6 900 Q4 Metrology & Production Solu
Slide 6: Partly challenging market environment influenced revenue development
Partly challenging market environment influenced revenue development Revenue in MEUR In million euros 2025 2024 Change in % 1200 − 6.3% 1,115.8 Semiconductor & Advanced Manufacturing 434.4 491.8 −11.7 1,046.0 300.7 Biophotonics 245.4 222.2 10.4 292.8 900 Metrology & Production Solutions 206.7 222.2
Slide 7: Revenue increase in the Americas
Revenue increase in the Americas Revenue by region 2025 Revenue by region in million euros 2024 Europe 5% 309.8 −7.1% (without 24% Germany) 333.4 17% 254.5 Germany −20.1% 318.3 253.7 Americas +4.1% 243.8 24% 175.7 30% Asia / Pacific −4.1% 183.2 Middle East / 52,3 Africa +40.8% 37.1 Middle East / Afr
Slide 8: Lower revenue, product mix effects and expenses for cost reduction measures impacted profitability
Lower revenue, product mix effects and expenses for cost reduction measures impacted profitability EBITDA in MEUR EBITDA million euros EBITDA margin in % 250 − 13.1% 2025 2024 2025 2024 221.5 61.0 Semiconductor & Advanced 200 192.5 Manufacturing 114.2 139.9 25.7 27.9 60.7 Biophotonics 52.2 29.5 21.1
Slide 9: Strict cost management could not fully compensate revenue decline
Strict cost management could not fully compensate revenue decline In million euros 2025 2024 Change in % − Gross margin influenced in particular by lower contribution of Semiconductor & Advanced Revenue 1,046.0 1,115.8 −6.3 Manufacturing Gross margin 32.1% 33.4% − Functional cost ratio amounted to 2
Slide 10: Financial position and balance sheet ratios significantly improved once again
Financial position and balance sheet ratios significantly improved once again In million euros 2025 2024 Change in % Cash flows from operating 223.9 193.0 16.1 activities before income taxes − Cash flows from operating activities: reduction (prior year increase) in working capital more than offset C
Slide 11: Outlook
Outlook
Slide 12: Return to profitable growth expected
Return to profitable growth expected Semiconductor & Advanced Manufacturing Targets 2026 − Revenue increase in single-digit percentage range (2025: 1,046.0m euros) Biophotonics − EBITDA margin between 19.0 and 21.0 percent (2025: 18.4%) − Investments slightly below prior year (2025: 77.4m euros) Met
Slide 13: Appendix
Appendix
Slide 14: Overview of quarters 2024 and 2025
Overview of quarters 2024 and 2025 In million euros Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Q2/2025 Q3/2025 Q4/2025 2025 Revenue 256.1 284.7 274.3 300.7 1,115.8 243.6 254.8 254.8 292.8 1,046.0 EBITDA 44.5 56.9 59.1 61.0 221.5 36.2 42.6 53.0 60.7 192.5 EBITDA margin in % 17.4 20.0 21.6 20.3 19.9
Slide 15: Key figures by segment 2025
Key figures by segment 2025 Semiconductor & Metrology & Advanced Production Smart Mobility in million euros Manufacturing Biophotonics Solutions Solutions Group2) Revenue1) 434.4 245.4 206.7 129.7 1,046.0 EBITDA 114.2 52.2 16.1 17.7 192.5 EBITDA margin in % 25.7 21.1 7.8 13.6 18.4 Order intake1) 404
Slide 16: Quarterly key figures by segment 2025
Quarterly key figures by segment 2025 Semiconductor & Advanced Manufacturing Biophotonics in million euros Q1 Q2 Q3 Q4 in million euros Q1 Q2 Q3 Q4 Revenue1) 100.9 108.2 105.8 119.5 Revenue1) 63.8 55.5 62.9 63.3 EBITDA 21.4 26.6 30.3 36.0 EBITDA 15.6 9.8 13.7 13.1 EBITDA margin in % 20.5 23.9 27.8 2
Slide 17: Quarterly key figures by segment 2025
Quarterly key figures by segment 2025 Metrology & Production Solutions Smart Mobility Solutions in million euros Q1 Q2 Q3 Q4 in million euros Q1 Q2 Q3 Q4 Revenue1) 40.6 51.4 47.0 67.7 Revenue1) 28.7 33.0 32.7 35.3 EBITDA –3.4 3.5 1.7 14.3 EBITDA 1.9 3.9 5.6 6.3 EBITDA margin in % –8.3 6.7 3.7 21.1 E
Slide 18: New organizational and reporting structure
New organizational and reporting structure Semiconductor & Metrology & Smart Mobility Advanced Biophotonicss Production Solutions Manufacturing Solutions − Optical and micro-optical − Optical components for − Systems and service for − Camera systems and components for the life science & medical insp
Slide 19: Dates and contact
Dates and contact 25.03.2026 Consolidated Financial Statements 2025 26.03.2026 Jefferies Conference, London 31.03.2026 Roadshow Frankfurt/Main 29.04.2026 Roadshow Paris 12.05.2026 Q1/2026 13.05.2026 UBS Conference, London Andreas Theisen Sabine Barnekow https://www.jenoptik.com Head of Investor Rela